Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics Lays Off Staff

NEW YORK (GenomeWeb) – Cancer Genetics announced after the close of the market on Friday that it is laying off an undisclosed number of employees and restructuring its functions. 

The moves are part of an effort to consolidate and reduce costs related to administrative, finance, and operational support functions. 

Additionally, Cancer Genetics said that Edward Sitar will leave the firm as chief financial officer and treasurer, effective Feb. 3. Victor Cross, who joined the firm in October 2016, has been promoted to chief accounting officer. Cross and Chief Operating officer and Executive Vice President of Finance John Roberts will take over Sitar's responsibilities. 

The company said that the moves are expected to positively impact its income statement in the second quarter.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.